PDL BioPharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

PDLI 2.72 -0.01 (-0.37%)
price chart
Here's Why PDL BioPharma Inc. Is Soaring Today
Shares of PDL BioPharma Inc. (NASDAQ:PDLI), a biopharma royalty company, are surging Friday in response to the positive second-quarter earnings report it issued after the bell Thursday.
PDL BioPharma Announces Second Quarter 2017 Financial Results  PR Newswire (press release)
PDL BioPharma to Announce Second Quarter 2017 Financial Results on August 3, 2017
INCLINE VILLAGE, Nev., July 31, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the Company will release its second quarter financial results for the period ended June 30, 2017, on Thursday, ...
A Look At Recent Insider Trades For PDL BioPharma, Inc. (PDLI)  Economic News
PDL BioPharma, Inc. (PDLI) Shares Bought by Credit Agricole SA  Sports Perspectives
3 Reasons Why PDL BioPharma (PDLI) is a Great Momentum Stock
This method discovered several great candidates for momentum-oriented investors, but today let's focus in on PDL BioPharma, Inc.PDLI as this stock is looking especially impressive right now. And while there are numerous ways in which this company could ...
Drilling Down Into the Books for PDL BioPharma, Inc. (PDLI)  StockNewsGazette
Revenue Estimates Analysis PDL BioPharma, Inc. (PDLI)  News Oracle
PDL BioPharma (PDLI) Q2 Earnings Beat, Revenues Rise Y/Y
PDL BioPharma, Inc. PDLI reported earnings of 26 cents per share in the second quarter of 2017, surpassing both the Zacks Consensus Estimate and the year-ago earnings of 9 cents per share.
PDL Biopharma Inc (NASDAQ:PDLI) Institutional Investor Sentiment  BZ Weekly
Intraday Mover -: PDL BioPharma, Inc. (PDLI)  Hot Stocks Point
A Look at 2 Trending Stocks: Novartis AG (NVS), PDL BioPharma, Inc. (PDLI)
Turning to PDL BioPharma, Inc. (NASDAQ:PDLI), its shares were trading at $2.73 a retreat of $-0.06, on the trading floor.
Pdl Biopharma Inc (PDLI) Facts and Figures
Pdl Biopharma Inc (NASDAQ:PDLI) has grabbed attention from the analysts, when it saw a value increase of 0% or 0 points in the last trading session to close at $2.79.
Analytical Overview of PDL BioPharma, Inc. (PDLI)  FactsReporter
PDL BioPharma, Inc. (NASDAQ:PDLI) Rating Increased to Hold at BidaskClub  ExpressNewsline
Shares Running on Volume: PDL BioPharma Inc (PDLI)
Shares of PDL BioPharma Inc (PDLI) have seen the needle move 1.83% or 0.05 in the most recent session. The NASDAQ listed company saw a recent bid of $2.78 on 1059871 volume.
Analysts think these stock's can be a game changer: Alphabet Inc. (GOOGL), PDL ...
Alphabet Inc. (NASDAQ:GOOGL) market capitalization at present is $632.59B at the rate of $927.66 a share. The firm's price-to-sales ratio was noted 6.53 in contrast with an overall industry average of 7.53.
PDL BioPharma, Inc. (NASDAQ:PDLI) Traded Significantly Above Its 50 Day Average
The value of the position overall is up by 11.7%. As of quarter end Sterling Capital Management LLC had bought a total of 140,490 shares growing its position 68.6%.
UBS Asset Management Americas Inc. Cuts Position in PDL BioPharma, Inc. (PDLI)
PDL BioPharma logo UBS Asset Management Americas Inc. cut its stake in PDL BioPharma, Inc. (NASDAQ:PDLI) by 99.6% during the first quarter, according to its most recent 13F filing with the SEC.